A randomized comparative trial of adriam
β
Dr. Joan M. Bull; Douglass C. Tormey; Shou-Hua Li; Paul P. Carbone; Geoffrey Fal
π
Article
π
1978
π
John Wiley and Sons
π
English
β 551 KB
A prospective randomized trial was conducted comparing the clinical response of 78 previously untreated patients with advanced metastatic breast cancer to a combination of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) or to a combination of cyclophosphamide, adriamycin, and 5-fluorouracil